Overview A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis Status: Completed Trial end date: 2020-10-29 Target enrollment: Participant gender: Summary This is a study to assess the long-term safety and tolerability of bimekizumab in subjects with psoriatic arthritis Phase: Phase 2 Details Lead Sponsor: UCB Biopharma S.P.R.L.UCB Biopharma SRL